Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Alberto Losada-Garcia"'
Autor:
Marian Cruz-Burgos, Alberto Losada-Garcia, Carlos D. Cruz-Hernández, Sergio A. Cortés-Ramírez, Ignacio Camacho-Arroyo, Vanessa Gonzalez-Covarrubias, Miguel Morales-Pacheco, Samantha I. Trujillo-Bornios, Mauricio Rodríguez-Dorantes
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The use of already-approved drugs to treat new or alternative diseases has proved to be beneficial in medicine, because it reduces both drug development costs and timelines. Most drugs can be used to treat different illnesses, due their mechanisms of
Externí odkaz:
https://doaj.org/article/dc77b545e4fe4f3595868b0363f554a5
Autor:
Vanessa Gonzalez-Covarrubias, Alberto Losada-Garcia, Ignacio Camacho-Arroyo, Martha E. Albino-Sánchez, Monserrat Llaguno-Munive, José L Cruz-Colin, Carlos Pérez-Plasencia, Sergio Alberto Cortés-Ramírez, Marian Cruz-Burgos, Patricia García-López, Carlos D. Cruz-Hernández, Elizabeth Langley, Fredy O. Beltrán-Anaya, Mauricio Rodríguez-Dorantes
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-13 (2020)
Cancer Cell International
Cancer Cell International
Background Prostate cancer (PCa) is the second cause of cancer related death in North American men. Androgens play an important role in its progression by regulating the expression of several genes including fusion ones that results from structural c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d8b6c9c80dc6b799834c09aabfad3b9
http://link.springer.com/article/10.1186/s12935-020-01333-5
http://link.springer.com/article/10.1186/s12935-020-01333-5
Autor:
Samantha I. Trujillo-Bornios, Marian Cruz-Burgos, Mauricio Rodríguez-Dorantes, Alberto Losada-Garcia, Ignacio Camacho-Arroyo, Sergio Alberto Cortés-Ramírez, Vanessa Gonzalez-Covarrubias, Miguel Morales-Pacheco, Carlos D. Cruz-Hernández
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
The use of already-approved drugs to treat new or alternative diseases has proved to be beneficial in medicine, because it reduces both drug development costs and timelines. Most drugs can be used to treat different illnesses, due their mechanisms of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9505ff53104a999bbc20689a41ccddd3
https://pubmed.ncbi.nlm.nih.gov/33718200
https://pubmed.ncbi.nlm.nih.gov/33718200
Autor:
Alberto Losada-Garcia, Sergio Alberto Cortés-Ramírez, Vanessa Gonzalez-Covarrubias, Juan Pablo Reyes-Grajeda, Mauricio Rodríguez-Dorantes, Carlos D. Cruz-Hernández, Jenie Marian Cruz-Burgos
Publikováno v:
Methods in Molecular Biology ISBN: 9781071607589
In the treatment of cancer, over the last decade different drugs delivery systems have been developed to increase therapeutic specificity to improve drug's efficacy, and safety by increasing bioavailability. Among these systems, small nucleic acid mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26c43e45d99c39bab1924cfa5ba5fe5b
https://doi.org/10.1007/978-1-0716-0759-6_15
https://doi.org/10.1007/978-1-0716-0759-6_15
Autor:
Mauricio, Rodríguez-Dorantes, Carlos David, Cruz-Hernandez, Sergio Alberto, Cortés-Ramírez, Jenie Marian, Cruz-Burgos, Juan Pablo, Reyes-Grajeda, Oscar, Peralta-Zaragoza, Alberto, Losada-Garcia
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2174
Prostate cancer is one of the main causes of cancer and the sixth cause of death among men worldwide. One of the major challenges in prostate cancer research is cell heterogeneity defined as the different genomic and phenotypic characteristics in eac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b9343bc45a7cb0cddc6c6c5e55f7b93d
https://pubmed.ncbi.nlm.nih.gov/32813241
https://pubmed.ncbi.nlm.nih.gov/32813241
Autor:
Alberto Losada-García, Iván Salido-Guadarrama, Sergio Alberto Cortes-Ramirez, Marian Cruz-Burgos, Miguel Morales-Pacheco, Karla Vazquez-Santillan, Griselda Rodriguez-Martinez, Imelda González-Ramírez, Vanessa Gonzalez-Covarrubias, Carlos Perez-Plascencia, Mauricio Rodríguez-Dorantes
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
Prostate cancer (PCa) ranks second in incidence and sixth in deaths globally. The treatment of patients with castration-resistant prostate cancer (CRPC) continues to be a significant clinical problem. Emerging evidence suggests that prostate cancer p
Externí odkaz:
https://doaj.org/article/a0b7dd681d7e4ad79a43278dcca13db8
Autor:
Carlos D. Cruz-Hernández, Marian Cruz-Burgos, Sergio A. Cortés-Ramírez, Alberto Losada-García, Ignacio Camacho-Arroyo, Patricia García-López, Elizabeth Langley, Vanessa González-Covarrubias, Monserrat Llaguno-Munive, Martha E. Albino-Sánchez, José L. Cruz-Colín, Carlos Pérez-Plasencia, Fredy O. Beltrán-Anaya, Mauricio Rodríguez-Dorantes
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Background Prostate cancer (PCa) is the second cause of cancer related death in North American men. Androgens play an important role in its progression by regulating the expression of several genes including fusion ones that results from str
Externí odkaz:
https://doaj.org/article/f04cd89727b9453c9cb8d7ea23d883a5
Autor:
Carlos David Cruz-Hernández, Griselda Rodríguez-Martínez, Sergio A. Cortés-Ramírez, Miguel Morales-Pacheco, Marian Cruz-Burgos, Alberto Losada-García, Juan Pablo Reyes-Grajeda, Imelda González-Ramírez, Vanessa González-Covarrubias, Ignacio Camacho-Arroyo, Marco Cerbón, Mauricio Rodríguez-Dorantes
Publikováno v:
Biomolecules, Vol 12, Iss 8, p 1056 (2022)
Despite of the capacity that several drugs have for specific inhibition of the androgen receptor (AR), in most cases, PCa progresses to an androgen-independent stage. In this context, the development of new targeted therapies for prostate cancer (PCa
Externí odkaz:
https://doaj.org/article/a9727c49c22b4ca8a98df13ed5392d3e